Voleon Capital Management LP bought a new position in Kimberly-Clark Co. (NYSE:KMB – Free Report) during the 4th quarter, Holdings Channel.com reports. The institutional investor bought 19,414 shares of the company’s stock, valued at approximately $2,544,000.
Other institutional investors have also recently bought and sold shares of the company. Migdal Insurance & Financial Holdings Ltd. acquired a new position in shares of Kimberly-Clark in the 4th quarter valued at about $25,000. Marshall Investment Management LLC acquired a new position in Kimberly-Clark during the fourth quarter valued at approximately $25,000. Golden State Wealth Management LLC purchased a new stake in Kimberly-Clark during the fourth quarter worth approximately $32,000. Strategic Financial Concepts LLC acquired a new stake in shares of Kimberly-Clark in the fourth quarter worth $33,000. Finally, Roxbury Financial LLC purchased a new position in shares of Kimberly-Clark in the 4th quarter valued at $33,000. 76.29% of the stock is currently owned by hedge funds and other institutional investors.
Kimberly-Clark Trading Up 0.8 %
NYSE KMB opened at $131.63 on Thursday. The company has a debt-to-equity ratio of 7.05, a quick ratio of 0.54 and a current ratio of 0.80. The company has a 50-day simple moving average of $139.14 and a 200-day simple moving average of $135.32. Kimberly-Clark Co. has a one year low of $124.10 and a one year high of $150.45. The firm has a market capitalization of $43.68 billion, a PE ratio of 17.43, a price-to-earnings-growth ratio of 4.46 and a beta of 0.37.
Analyst Upgrades and Downgrades
Several analysts recently issued reports on the company. TD Cowen downgraded Kimberly-Clark from a “buy” rating to a “hold” rating and set a $145.00 price target for the company. in a report on Wednesday, January 8th. Royal Bank of Canada reduced their target price on shares of Kimberly-Clark from $165.00 to $162.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. Barclays cut their price target on Kimberly-Clark from $139.00 to $135.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 24th. JPMorgan Chase & Co. raised their price objective on Kimberly-Clark from $124.00 to $131.00 and gave the company an “underweight” rating in a research note on Friday, April 11th. Finally, UBS Group upped their target price on Kimberly-Clark from $134.00 to $146.00 and gave the company a “neutral” rating in a research report on Thursday, April 17th. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, Kimberly-Clark presently has a consensus rating of “Hold” and a consensus price target of $145.08.
Get Our Latest Research Report on KMB
Insider Activity
In other Kimberly-Clark news, VP Andrew Drexler sold 2,500 shares of the business’s stock in a transaction dated Friday, February 21st. The shares were sold at an average price of $140.00, for a total transaction of $350,000.00. Following the completion of the transaction, the vice president now directly owns 2,553 shares of the company’s stock, valued at $357,420. The trade was a 49.48 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Katy Chen sold 1,794 shares of the firm’s stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $130.74, for a total transaction of $234,547.56. Following the completion of the sale, the insider now owns 3,098 shares in the company, valued at $405,032.52. The trade was a 36.67 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 15,132 shares of company stock valued at $2,112,706. 0.64% of the stock is currently owned by company insiders.
About Kimberly-Clark
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Recommended Stories
- Five stocks we like better than Kimberly-Clark
- What Are Dividend Achievers? An Introduction
- Why D-Wave’s Project With Davidson Is a Game-Changer For Quantum
- Financial Services Stocks Investing
- Hims & Hers Stock Soars on Novo Nordisk Collaboration
- Following Congress Stock Trades
- Amazon’s Earnings Will Make or Break the Stock’s Comeback
Want to see what other hedge funds are holding KMB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kimberly-Clark Co. (NYSE:KMB – Free Report).
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.